Effects of Somatostatin on ADPKD Heart

NCT02119013 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease
Glomerular Filtration Rate > 40 ml/Min

Interventions

DRUG: Octeotride
DRUG: Placebo

Sponsor

Federico II University